pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
Coronavirus Disease 2019 (COVID-19) vaccine 1
Covid-19 Vaccine (mivalsecovatein [INN])
Coronavirus Disease 2019 (COVID-19)
$NVAX
NOVAVAX INC
Preclinical
Coronavirus Disease 2019 (COVID-19) vaccines
Coronavirus Disease 2019 (COVID-19)
University of Florida
Marketed
Coronavirus Disease 2019 (SARS-CoV-2) vaccine 2
Spikevax Omicron XBB.1.5
Coronavirus Disease 2019 (COVID-19)
$MRNA
Moderna, Inc.
← prev
page 82 of 271
next →
Pain
89
Neurology
1
Marketed
Cortef
Cortef (hydrocortisone acetate)
Acute Rheumatic Heart Disease
$PFE
PFIZER INC
Marketed
Cortenema
Cortenema (hydrocortisone [INN])
Proctitis
$ANIP
ANI PHARMACEUTICALS INC
Marketed
Cortifoam
Cortifoam (hydrocortisone acetate)
Proctitis
Mylan Specialty LP
Marketed
Creon
Creon (pancrelipase)
Exocrine Pancreatic Insufficiency
$ABBV
AbbVie Inc.
Marketed
Crestor
Crestor (rosuvastatin calcium)
Atherosclerosis
AstraZeneca Pharmaceuticals LP
Marketed
Crexont
Crexont ((carbidopa + levodopa))
Parkinson's Disease
$AMRX
Amneal Pharmaceuticals, Inc.
Preclinical
Culnexin Inhibitors
Triple-Negative Breast Cancer (TNBC)
Culnexin Therapeutics LLC
Marketed
Cusimolol
Timolol Maleate
Ocular Hypertension
Eon Labs Inc
Marketed
Cutaquig
Cutaquig (immune globulin (human))
Primary Immune Deficiency (PID)
$PFE
PFIZER INC
Marketed
Cutivate
Cutivate Fougera (fluticasone propionate)
Atopic Dermatitis (Atopic Eczema)
Fougera Pharmaceuticals Inc
Marketed
Cuvitru
Cuvitru (immune globulin (human))
Primary Humoral Immune Deficiencies
Takeda Pharmaceuticals USA Inc
Phase 2
CybroCell
Degenerative Disc Disease
$FBLG
FibroBiologics, Inc.
Marketed
Cyclobenzaprine Hydrochloride Teva
Cyclobenzaprine Hydrochloride
Muscle Spasm
Pliva Inc (Inactive)
Marketed
Cyfendus
Cyfendus
Anthrax
$EBS
Emergent BioSolutions Inc.
Marketed
Cytarabine Pfizer
Cytarabine
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
$PFE
PFIZER INC
Preclinical
Cyto-111
Botulism
CytoDel Inc
Phase 2
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK)
Refractory Acute Myeloid Leukemia
Cincinnati Children's Hospital Medical Center
Marketed
Cytoxan
Cytoxan (cyclophosphamide [INN])
Nephrotic Syndrome
Baxter Healthcare Corp
Phase 2
D-0120
Gouty Arthritis (Gout)
InventisBio Co Ltd
Phase 1
D-121
Visceral Leishmaniasis (Kala-Azar)
Oblita Therapeutics BVBA
Marketed
D-Penamine
Depen (penicillamine)
Rheumatoid Arthritis
Mylan Specialty LP
Preclinical
D-Psilocybin
Major Depressive Disorder
Lennham Pharmaceuticals Inc
Phase 2
D2C7-IT
Glioblastoma Multiforme (GBM)
Istari Oncology Inc
Phase 1
D3L-001
Gastric Cancer
D3 Bio Inc
Phase 2
D3S-002
Non-Small Cell Lung Cancer
D3 Bio Inc
Phase 1
D3S-003
Solid Tumor
D3 Bio Inc
Phase 1
DA-1726
Obesity
$MTVA
MetaVia Inc.
